| Dear Investment U Reader, Quick reminder... Tomorrow morning at 10:00 a.m., one small $7 biotech will make a presentation at the 33rd Annual J.P. Morgan Healthcare Conference that could ignite its shares. Here's the scoop... This company just released a technology that will dramatically change healthcare in this country. Already, it's at full throttle with a swarm of orders from pharmaceuticals, hospitals and research labs across the globe. What's more, the Centers for Disease Control and Prevention (CDC) plans to give this tiny company a rare sole source contract. That means this company is the only one in existence that can provide a service and that the CDC will never accept competing bids from other companies. That gives this company an edge in the market far and above its competitors. And tomorrow's presentation could take this tiny firm to the next level. You'll need to act fast, because this is your absolute last chance to get in before the presentation occurs. Sincerely, Andrew Snyder Editorial Director, The Oxford Club
| 
No comments:
Post a Comment
Keep a civil tongue.